π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
With the advent of new treatments for ASI, new phenotypes are emerging. The...
Status
Recruiting
Location
Pediatric Rehabilitation Service - L'Escale Mother and Child Hospital
Start Date
2024-07-24
Trial ID
NCT06321965
The objective of this randomized clinical trial is to test whether administ...
Status
Completed
Location
Clinical and Translational Research Center
Start Date
2020-09-22
Trial ID
NCT04475081
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as gemcitabine hydrochloride, c...
Status
Completed
Location
Sussex Cancer Centre at Royal Sussex County Hospital
Start Date
2006-03
Trial ID
NCT00971763
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
1998-06-02
Trial ID
NCT00005792
Treatments Being Tested
The purpose of this study is to evaluate the safety and immunogenicity of B...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-07-27
Trial ID
NCT03621670
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Unknown
Location
Nottingham City Hospital
Start Date
2006-01
Trial ID
NCT00974792
The purpose of this study is to assess the consistency of immune response t...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2025-01-10
Trial ID
NCT06740630
Primary objective: This study aimed to demonstrate the non-inferiority of ...
Status
Completed
Location
Investigational Site Number : 2031006
Start Date
2018-12-14
Trial ID
NCT03547271
The purpose of this study is to see if the study drugs, lenvatinib and pemb...
Status
Active Not Recruiting
Location
Baptist Alliance MCI
Start Date
2020-06-02
Trial ID
NCT04209660
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Status
Completed
Location
Veterans Affairs Medical Center - Palo Alto
Start Date
2006-09-26
Trial ID
NCT00274924